Business Description
Emyria Ltd
ISIN : AU0000073645
Share Class Description:
ASX:EMD: Ordinary SharesTotal Employee Number:
7,500Description
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 18.86 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.14 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.83 | |||||
Beneish M-Score | -2.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.7 | |||||
3-Year EBITDA Growth Rate | 38.7 | |||||
3-Year EPS without NRI Growth Rate | 36.2 | |||||
3-Year FCF Growth Rate | 40.2 | |||||
3-Year Book Growth Rate | -26.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.42 | |||||
9-Day RSI | 49.47 | |||||
14-Day RSI | 46.89 | |||||
3-1 Month Momentum % | -2 | |||||
6-1 Month Momentum % | -16.95 | |||||
12-1 Month Momentum % | 75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.76 | |||||
Quick Ratio | 10.76 | |||||
Cash Ratio | 10.26 | |||||
Days Sales Outstanding | 51.81 | |||||
Days Payable | 128.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.2 | |||||
Shareholder Yield % | -41.18 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 17.05 | |||||
Operating Margin % | -211.97 | |||||
Net Margin % | -206.3 | |||||
EBITDA Margin % | -184.17 | |||||
FCF Margin % | -171.2 | |||||
OCF Margin % | -168.57 | |||||
ROE % | -65.56 | |||||
ROA % | -53.9 | |||||
ROIC % | -152.96 | |||||
3-Year ROIIC % | -275.21 | |||||
ROC (Joel Greenblatt) % | -523.17 | |||||
ROCE % | -59.85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 13.33 | |||||
PB Ratio | 2.67 | |||||
Price-to-Tangible-Book | 4 | |||||
EV-to-EBIT | -4.97 | |||||
EV-to-EBITDA | -5.5 | |||||
EV-to-Revenue | 10.12 | |||||
EV-to-FCF | -5.27 | |||||
Price-to-GF-Value | 1.33 | |||||
| Price-to-Net-Current-Asset-Value | 4 | |||||
| Price-to-Net-Cash | 4 | |||||
Earnings Yield (Greenblatt) % | -20.12 | |||||
FCF Yield % | -11.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Emyria Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 2.205 | ||
| EPS (TTM) (A$) | -0.009 | ||
| Beta | 0.732 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.53 | ||
| Volatility % | 79.92 | ||
| 14-Day RSI | 46.89 | ||
| 14-Day ATR (A$) | 0.002012 | ||
| 20-Day SMA (A$) | 0.0409 | ||
| 12-1 Month Momentum % | 75 | ||
| 52-Week Range (A$) | 0.026 - 0.078 | ||
| Shares Outstanding (Mil) | 806.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Emyria Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Emyria Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Emyria Ltd Frequently Asked Questions
What is Emyria Ltd(ASX:EMD)'s stock price today?
The current price of ASX:EMD is A$0.04. The 52 week high of ASX:EMD is A$0.08 and 52 week low is A$0.03.
When is next earnings date of Emyria Ltd(ASX:EMD)?
The next earnings date of Emyria Ltd(ASX:EMD) is .
Does Emyria Ltd(ASX:EMD) pay dividends? If so, how much?
Emyria Ltd(ASX:EMD) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Largest Australian Health Insurer to Fund Innovative PTSD Treatment Program | 2025-06-18 |
Articles on Emyria Ltd
No articles.